Article preview from Start-Up - March, 2012
It’s been a long road for MicroCHIPS, founded in 1999 to develop an implantable device capable of delivering discrete drug doses repeatedly over long periods of time. The company recently published results of its first clinical trial, establishing proof-of-concept and perhaps more importantly, indicating that after many years, it now has a focused plan, if not a timeline, for commercialization.
Article preview from Start-Up - March, 2012
It’s been a long road for MicroCHIPS Inc., which was founded in 1999 to develop an implantable drug delivery device capable of discrete drug dosing repeatedly over long periods of time. In February, the company published the results of a first-in-man clinical trial of the device. The data established proof-of-concept; specifically, the ability to deliver the osteoporosis drug Forteo (parathyroid hormone, or PTH) daily for 19 days with comparable bioequivalence to subcutaneous injections. More importantly, after many years, the company now has a firm, focused plan, if not a timeline, for commercialization.
MicroCHIPS started out as an extension of graduate work at the Massachusetts Institute of Technology Research Labs, led by founding inventors Michael Cima, PhD, and Robert Langer, ScD, and John Santini, Jr., PhD, then a doctoral student in their labs. It had, and continues to have, a strong syndicate of venture capitalists behind it, including founding investor Polaris Venture Partners, Medtronic Inc., Intersouth Partners, Care Capital and IDG Ventures.
Continued...
To read this article in its entirety, purchase now as a PDF and receive it immediately via email. Or get it FREE when you subscribe to Start-Up.
About Start-Up
No publication reviews leading edge companies and technology better than Start-Up. Each issue of Start-Up profiles the most important new product companies, identifies the hottest technology areas, reviews funds flowing into private companies and investment trends, and reports on university tech transfer licensing. Industries covered: pharmaceuticals, biotechnology, medical equipment & devices, and in vitro diagnostics.
Plus:
To find out about more about more about Elsevier Business Intelligence's medical device publications and databases, multi-user access and/or advertising with Medical Devices Today, please contact Kristy Kennedy at (480) 985-9512
Comments